Cambridge Investment Research Advisors »

Nektar Therapeutics shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $118k 126k 0.94
2023-12-31 $73k 130k 0.56
2023-09-30 $80k 135k 0.59
2023-06-30 $79k 137k 0.58
2023-03-31 $96k 137k 0.70
2022-12-31 $299k 132k 2.26
2021-06-30 $177k 10k 17.19
2021-03-31 $206k 10k 19.96
2020-12-31 $183k 11k 17.01
2020-09-30 $197k 12k 16.61
2020-06-30 $275k 12k 23.20
2020-03-31 $227k 13k 17.81
2019-12-31 $287k 13k 21.57
2019-09-30 $517k 15k 35.61
2019-06-30 $517k 15k 35.61
2019-03-31 $447k 13k 33.61
2018-12-31 $347k 11k 32.90
2018-09-30 $724k 12k 60.96
2018-06-30 $234k 4.8k 48.91
2018-03-31 $400k 3.8k 106.21
2017-12-31 $219k 3.7k 59.74